[AF] Tabaquismo

Pedro del Río Pérez mondrino en gmail.com
Vie Sep 30 21:19:27 CEST 2011


Mª Luisa, dale un vistazo (sobre todo al 5º):

Int J Chron Obstruct Pulmon Dis. 2008 June; 3(2): 239–251.
Published online 2008 June.
PMCID: PMC2629973
Copyright © 2008 Dove Medical Press Limited. All rights reserved
Smoking cessation therapy with varenicline
Uma M Mohanasundaram, Rajinder Chitkara, and Ganesh Krishna
Division of Pulmonary and Critical Care Medicine, Department of Medicine,
Stanford University School of Medicine, CA, USA
<http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629973/?tool=pubmed>

BMC Public Health. 2006; 6: 300.
Published online 2006 December 11. doi:  10.1186/1471-2458-6-300
PMCID: PMC1764891
Copyright © 2006 Wu et al; licensee BioMed Central Ltd.
Effectiveness of smoking cessation therapies: a systematic review and 
meta-analysis
Ping Wu,1 Kumanan Wilson,2 Popey Dimoulas,1 and Edward J Mills1,3
<http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764891/?tool=pubmed>

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor 
Partial
Agonist, Varenicline, for Smoking Cessation
Cheryl Oncken, MD; David Gonzales, PhD; Mitchell Nides, PhD; Stephen 
Rennard,
MD; Eric Watsky, MD; Clare B. Billing, MS; Richard Anziano, MS; Karen 
Reeves, MD;
for the Varenicline Study Group
Arch Intern Med. 2006;166:1571-1577.
<http://archinte.ama-assn.org/cgi/content/full/166/15/1571>

Smoking Cessation With Varenicline, a Selective 42 Nicotinic Receptor 
Partial Agonist
Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial
With 1-Year Follow-up
Mitchell Nides, PhD; Cheryl Oncken, MD, MPH; David Gonzales, PhD; Stephen 
Rennard,
MD; Eric J. Watsky, MD; Rich Anziano, MS; Karen R. Reeves, MD; for the 
Varenicline Study Group
Arch Intern Med. 2006;166:1561-1568.
<http://archinte.ama-assn.org/cgi/content/full/166/15/1561>

JAMA-EXPRESS
JAMA. 2006;296(1):64-71. doi: 10.1001/jama.296.1.64
Effect of Maintenance Therapy With Varenicline on Smoking Cessation
A Randomized Controlled Trial
<http://jama.ama-assn.org/content/296/1/64.long>

AGONISTAS PARCIALES DE LOS RECEPTORES DE LA NICOTINA PARA EL ABANDONO DEL 
HÁBITO DE FUMAR
<http://www.bibliotecacochrane.com/BCPGetDocument.asp?SessionID=%202215676&DocumentID=CD006103>

INTERVENCIONES PARA LA PREVENCIÓN DE LA REINCIDENCIA EN EL HÁBITO DE FUMAR
<http://www.bibliotecacochrane.com/BCPGetDocument.asp?SessionID=%202215676&DocumentID=CD003999>

Yo no he leído entero ninguno.
Ya eso te lo dejo para tí, ahora que viene el fin de semana y estarás muy 
aburrida.
;-)


Saludos
.............................................
Pedro del Río Pérez
León
pedrodelrio en uninet.edu
.............................................




-----Mensaje original----- 
De: Mª Luisa Reynolds Martinez
Fecha: jueves, 29 de septiembre de 2011 13:59
Para: AF - Uninet
Asunto: [AF] Tabaquismo

A ver, a los expertos en tabaco ¿ que opináis?
Cuando un paciente toma champix hay unas pautas posologicas, en 



Más información sobre la lista de distribución AF